J Korean Soc Neonatol.  2003 May;10(1):83-87.

Down Syndrome with Transient Myeloproliferative Disorder, Hepatic Fibrosis, and Hemochromatosis

Affiliations
  • 1Department of Pediatrics, Wonju Medical College, Yonsei University, Wonju, Korea. limbk@kornet.net
  • 2Department of Laboratory Medicine, Wonju Medical College, Yonsei University, Wonju, Korea.
  • 3Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Transient myeloproliferative disorder (TMD), which may mimic acute leukemia, occurs in neonates with Down syndrome along with hepatic fibrosis. TMD is recognized shortly after birth or in the neonatal period and is characterized by leukocytosis and thrombocytopenia, which resolve spontaneously in four to six weeks. And hepatic fibrosis is characterized by diffuse intralobular sinusoidal fibrosis, extramedullary hematopoiesis and hemochromatosis. A newborn male infant with Down syndrome, atrial septal defect and ventricular septal defect is reported. He showed abnormal myelopoiesis accompanying characteristic hepatic sinusoidal fibrosis. Knowing the cellular mechanism of hepatic fibrosis and its modulation by growth factors, a pathogenetic link between transient myeloproliferative disorder and the development of liver fibrosis in Down syndrome neonates, association of this triad no longer appears to be accidental.

Keyword

Down syndrome; Transient myeloproliferative disorder; Hepatic fibrosis; Hemochromatosis

MeSH Terms

Down Syndrome*
Fibrosis*
Heart Septal Defects, Atrial
Heart Septal Defects, Ventricular
Hematopoiesis, Extramedullary
Hemochromatosis*
Humans
Infant
Infant, Newborn
Intercellular Signaling Peptides and Proteins
Leukemia
Leukocytosis
Liver Cirrhosis
Male
Myelopoiesis
Myeloproliferative Disorders*
Parturition
Thrombocytopenia
Intercellular Signaling Peptides and Proteins
Full Text Links
  • JKSN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr